Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis)

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 50-60

  Yamano, Yoshihisa ^a   Kitze, Bernd ^a,b   Yashiki, Shinji ^a   Usuku, Koichiro ^a   Fujiyoshi, Toshinobu ^a   Kaminagayoshi, Tatsuhiko ^a   Unoki, Kazuhiko ^a   Izumo, Shuji ^a   Osame, Mitsuhiro ^a   Sonoda, Shunro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

CD4+ T cell epitopes; HAM TSP associated human leukocyte antigens; HTLV I gp21 envelope protein; HTLV I associated myelopathy tropical spastic paraparesis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; SYNTHETIC PEPTIDE; T LYMPHOCYTE ANTIGEN; VIRUS ENVELOPE PROTEIN;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; SPASTIC PARESIS; SPINAL CORD DISEASE; VIRUS ENVELOPE;

ALLELES; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE PRODUCTS, ENV; GENES, MHC CLASS II; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PARAPARESIS, TROPICAL SPASTIC; RETROVIRIDAE PROTEINS, ONCOGENIC;

EID: 0030916360     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00041-6     Document Type: Article

References (49)

1. Akaza, T., Imanishi, T., Fujiwara, K., Tokunaga, K., Yashiki, S., Fujiyoshi, T., Sonoda, S. and Juji, T. (1994) HLA alleles and haplotypes of Japanese population. MHC and IRS 1 (suppl.), 219-226.
2. Baba, E., Nakamura, M., Tanaka, Y., Kuroki, M., Itoyama, Y., Nakano, S. and Niho, Y. (1993) Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type I (HTLV-I) identified by human monoclonal antibodies: A basis for the design of an HTLV-I peptide vaccine. J. Immunol. 151, 1013-1024.
3. Baba, E., Nakamura, M., Ohkuma, K., Kira, J., Tanaka, Y., Nakano, S. and Niho Y. (1995) A peptide-based human T-cell leukemia virus type I vaccine containing T- and B-cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 154, 399-412.
4. Bartholomew, C., Cleghorn, F., Charles, W., Ratan, P., Roberts, L., Maharaj, K., Jankey, N., Daisley, H., Hanchard, B. and Blattner, W. (1986) HTLV-I and tropical spastic paraparesis. Lancet 2, 99-100.
5. Ben-Nun, A., Wekerle, H. and Cohen, I.R. (1981) The rapid isolation of clonable antigen-specific T-lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199.
6. Fields, G.B. and Nobel, R.L. (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161-214.
7. Gessain, A., Barin, F., Vernant, J.C., Gout, O., Maurs, L., Calender, A. and De-Thé, G. (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
8. *0101)-bound peptides. Immunogenetics 42, 299-301.
9. Gessain, A. and Gout, O. (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med. 117, 933-946.
10. Haraguchi, S., Good, R.A., James-Yarish, M., Cianciolo, G.J. and Day, N.K. (1995) Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopathogenesis in retroviral infections. Proc. Natl. Acad. Sci. USA 92, 5568-5571.
11. Höllsberg, P. and Hafler, D.A. (1993) Pathogenesis of disease induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328, 1173-1182.
12. Ijichi, S., Izumo, S., Eiraku, N., Machigashira, K., Kubota, R., Nagai, M., Ikegami, N., Kashio, N., Umehara, F., Maruyama, I. and Osame, M. (1993) An autoaggressive process against bystander tissues in HTLV-I-infected individuals: A possible pathomechanism of HAM/TSP. Med. Hypotheses 41, 542-547.
13. Ijichi, S. and Osame, M. (1995) Human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): Recent perspectives. Intern. Med. 34, 713-721.
14. Itoyama, Y., Minato, S., Kira, J., Goto, I., Sato, H., Okochi, K. and Yamamoto, N. (1988) Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38, 1302-1307.
15. Iwasaki, Y., Ohara, Y., Kobayashi, I. and Akizuki, S. (1992) Infiltration of helper/inducer T-lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am. J. Pathol. 140, 1003-1008.
16. +, human T-lymphotropic virus type-1-specific cytotoxic T-lymphocytes from patients with HAM/TSP. J. Immunol. 146, 1155-1162.
17. Jacobson, S. (1995) Human T-lymphotropic virus, type-I myelopathy: An immunopathologically mediated chronic progressive disease of the central nervous system. Curr. Opin. Neurol. 8, 179-183.
18. Jingwu, Z., Medaer, R., Hashim, G.A., Chin, Y., van-den-Berg-Loonen, E. and Raus, J.C.M. (1992) Myelin basic protein-specific T-lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity and cytotoxicity. Ann. Neurol. 32, 330-338.
19. Joshi, N., Usuku, K. and Hauser, S.L. (1993) The T-cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements and T-cell receptor usage. Ann. Neurol. 34, 385-393.
20. Kaplan, J.E., Osame, M. and Kubota, H. (1990) The risk of development of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) among persons infected with HTLV-I. J. Acquired Immune Defic. Syndr. 3, 1096-1101.
21. Katahira, Y., Yashiki, S., Fujiyoshi, T., Nomura, K., Tara, M., Mori, M., Setoyama, M., Kanzaki, T., Shida, H. and Sonoda, S. (1995) In vitro induction of cytotoxic T-lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn. J. Cancer. Res. 86, 21-27.
22. Kitze, B., Pette, M., Rohrbach, E., Stadt, D., Kappos, L. and Wekerle, H. (1988) Myelin-specific T-lymphocytes in multiple sclerosis patients and healthy individuals. J. Neuroimmunol. 20, 237.
23. Kitze, B., Usuku, K., Izumo, S., Nakamura, M., Shiraki, H., Ijichi S., Yashiki, S., Fujiyoshi, T., Sonoda, S. and Osame, M. (1996a) Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J. Neurol. 243, 393-400.
24. Kitze, B., Usuku, K., Yashiki, S., Ijichi, S., Fujiyoshi, T., Nakamura, M., Izumo, S., Osame, M. and Sonoda, S. (1996b) Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis. Acta. Neurol. Scand. 94, 287-293.
25. Kurata, A., Palker, T.J., Streilen, R.D., Scearce, R.M., Haynes, B.F. and Berzofsky, J.A. (1989) Immunodominant sites of human T-cell lymphotropic virus type I envelope protein for murine helper T-cells. J. Immunol. 143, 2024-2030.
26. Lal, R.B., Rudolph, D.L., Lairmore, M.D., Khabbaz, R.F., Garfield, M., Coligan, J.E. and Folks, T.M. (1991) Serologic discrimination of human T-cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay. J. Infect. Dis. 163, 41-46.
27. Lefkovits, I. and Waldmann, H. (1979) Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press, Cambridge, pp. 38-82.
28. + T-cell lines from HTLV-I seronegative individuals: Specificity and clonal heterogeneity. Blood 85, 1547-1554.
29. Mori, M., Ban, N. and Kinoshita, K. (1988) Familial occurrence of HTLV-I-associated myelopathy. Ann. Neurol. 23, 100.
30. Nagai, M., Yashiki, S., Fujiyoshi, T., Fujiyama, C., Kitze, B., Izumo, S., Osame, M. and Sonoda, S. (1996) Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J. Neuroimmunol. 65, 97-106.
31. Nishimura, Y., Okubo, R., Minato, S., Itoyama, Y., Goto, I., Mori, M., Hirayama, K. and Sasazuki, T. (1991) A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese. Tissue Antigens 37, 230-231.
32. Nomura, M., Ota, M., Tsuji, K. and Inoko, H. (1991) HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 38, 53-59.
33. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M. and Tara, M. (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031-1032.
34. Ota, M., Seki, T., Nomura, N., Sugimura, K., Mizuki, N., Fukushima, H., Tsuji, K. and Inoko, H. (1991) Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 38, 60-71.
35. Ota, M., Seki, T., Fukushima, H., Tsuji, K. and Inoko, H. (1992) HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39, 187-202.
36. Palker, T.J., Tanner, M.E., Scearce, R.M., Streilein, R.D., Clark, M.E. and Haynes, B.F. (1989) Mapping of immunogenic regions of human T-cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J. Immunol. 142, 971-978.
37. Palker, T.J., Riggs, E.R., Spragion, D.E., Muir, A.J., Scearce, R.M., Randall, R.R., Mcadams, M.W., Mcknight, A., Clapham, P.R., Weiss, R.A. and Haynes, B.F. (1992) Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J. Virol. 66, 5879-5889.
38. Pette, M., Fujita, K., Kitze, B., Whitaker, J.N., Albert, E., Kappos, L. and Wekerle, H. (1990) Myelin basic protein-specific T-lymphocyte lines from MS patients and healthy individuals. Neurology 40, 1770-1776.
39. Rammensee, H.G., Friede, T. and Stevanovic, S. (1995) MHC ligands and peptide motifs: First listing. Immunogenetics 41, 178-228.
40. Robert-Guroff, M., Markham, P.D., Popovic, M. and Gallo, R.C. (1985) Isolation, characterization, and biological effects of the first human retroviruses: The human T-lymphotropic retrovirus family. Curr. Top. Microbiol. Immunol. 115, 7-31.
41. Seiki, M., Hattori, S., Hirayama, Y. and Yoshida, M. (1983) Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80, 3618-3622.
42. Sonoda, S., Yashiki, S., Fujiyoshi, T., Arima, N., Tanaka, H., Eiraku, N., Izumo, S. and Osame, M. (1992) Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy. Gann Monogr. Cancer Res. 39, 81-93.
43. Sonoda, S., Fujiyoshi, T. and Yashiki, S. (1996) Immunogenetics of HTLV-I/II and associated diseases. J. Acquired Immune Defic. Syndr. 13, S119-S123.
44. Tanaka, Y., Zeng, L., Shiraki, H., Shida, H. and Tozawa, H. (1991) Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J. Immunol. 147, 354-360.
45. Terasaki, P.I., Bernoco, D., Park, M.S., Ozturk, G. and Iwaki, Y. (1978) Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am. J. Clin. Pathol. 69, 103-120.
46. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. and Uchino, H. (1977) Adult T-cell leukemia: Clinical and hematological features of 16 cases. Blood 50, 481-492.
47. Umehara, F., Izumo, S., Nakagawa, M., Ronquillo, A.T., Takahashi, K., Matsumuro, K., Sato, E. and Osame, M. (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 52, 424-430.
48. Usuku, K., Sonoda, S., Osame, M., Yashiki, S., Takahashi, K., Matsumoto, M., Sawada, T., Tsuji, K., Tara, M. and Igata, A. (1988) HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23, 143-150.
49. Wucherpfennig, K.W. and Strominger, J.L. (1995) Molecular mimicry in T-cell-mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelin basic protein. Cell 80, 695-705.